Prudential plc · PUK · FY2023 Q1 · Calendar Q1 2024

Prudential outlines health, China mix and ASEAN growth priorities

The current analysis supports a constructive operating thesis: strong 2023 growth, health expansion, China product-mix improvement and ASEAN distribution could support continued growth. The thesis remains dependent on execution, sustainable bank-assurance margins and effective deployment of planned investment.

Reported Before market openNYSEFinancial Services $30.78B market cap
80quality score

Earnings scorecard

Reported versus consensus
Reported EPS $0.69 Consensus —
EPS surprise — Reported versus consensus
Reported revenue $9.49B Consensus $28.04B
Revenue surprise -66.2% Reported versus consensus

Market reaction

prior-close to event-session close
Stock move -3.8% Event window
SPY move +0.9% Same window
Abnormal move -4.8% Stock minus SPY
Volume 2.5× Versus trailing sessions
Subsequent drift -6.2% Up to 20 sessions
PUKSPY benchmark

Ask FN2 about PUK FY2023 Q1

Transcript, numbers and history already loaded

Free account. Your question opens in FN2 with this report's transcript and numbers attached.

Transcript intelligence

What changed

Management highlighted a stronger health-growth agenda, a China product-mix shift away from the 3.5% guaranteed product, broader ASEAN bank partnerships and continued investment in distribution, customer experience and claims technology.

Guidance delta

Maintained: management reiterated a 15–20% new-business-profit growth target through 2027.

Key takeaways

  • 2023 sales reached $5.9bn, up 37%, while new-business profit reached $3.1bn, up 45%.
  • Hong Kong gained share in domestic and Mainland Chinese visitor segments.
  • China is shifting toward a more balanced product mix, with health and protection identified as growth areas.
  • Management plans more than $1bn of capability investment in distribution, customer experience and claims technology.

Management priorities

  • Expand bank-distribution partnerships across ASEAN.
  • Double the health business by 2027 through standalone products and claims-cost efficiencies.
  • Deploy the remaining $900m investment across distribution platforms, customer-experience tools and health AI.

Follow PUK with an agent that reads every filing, transcript, and price print. Free to start.

Try FN2 free

Earnings History

Estimate Beat Miss Match
PUK EPS earnings history estimate and actual scatter chart 3 reported fiscal quarters and 0 future estimate-only quarters. Q4 '23 actual $0.69, None Q4 '25 estimate $1.42 Q4 '25 actual $2.08, beat Q2 '26 estimate $1.28 Q2 '26 actual $0.76, miss

Analyst Consensus ?

ConsensusHold8 ratings
Bullish450.0%
Neutral337.5%
Bearish112.5%

Analyst 52W Price Targets

$23.92Current
$39.3Low
$39.3Average
$39.3High

Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 11, 2026. Not an FN2 forecast.

Firm-level rating actions

FMP grade actions identify the grading firm, not a named analyst.

FirmRatingPrior ratingActionDate
Goldman Sachs Buy BuyMaintainFeb 14, 2022
HSBC Buy HoldUpgradeMar 23, 2021
Macquarie Outperform OutperformMaintainOct 3, 2019
Evercore ISI Group In Line In LineMaintainJul 10, 2018
JP Morgan Neutral UnderweightUpgradeMar 17, 2017
Show 3 more rating actions

Named analyst price targets

Upside is calculated against the persisted current price $23.92. FMP does not supply a rating on these named-analyst rows.

FirmAnalyst52W targetPrice when postedUpsideDate
Berenberg BankMichael Huttner$39.3$27.29 +64.3%Sep 3, 2026

Track every rating change on PUK the moment it posts. Free to start.

Start free

Company context

Snapshot as of publication

Prudential plc, operating through its various subsidiaries, delivers a diverse array of financial solutions to individuals across Asia and Africa, encompassing life and health coverage, retirement planning, and comprehensive asset management services. Its product portfolio includes extensive health and protection plans, along with various savings instruments such as participating, unit-linked, and conventional policies.…

Historical context

All PUK earnings

Financial Services peers this season

Latest reports in the same sector

Latest beats and misses

Who reports next

Get the PUK recap when the next report posts

One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.

Sources

  1. Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
  2. FN2 earnings calendar · 2024-11-11T06:39:45.180704+00:00
  3. Polygon adjusted daily market bars · 2026-10-11T06:20:43.720272+00:00
  4. Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-10-11T06:20:43.717342+00:00

Methodology

Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.

Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.

Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.

By FN2 Research · Updated · As of 2026-10-11. For educational purposes only; not investment advice.